Afuresertib
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Afuresertib, covering 2016-05-04 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer [Phase 3]